In this presentation Dr. Pieper will continue the discussion on canine atopic dermatitis with a focus on moderate to severe cases of disease. His discussion will include:
- Characteristics of moderate to severe disease
- Current therapeutic options including JAK inhibitors (Apoquel and Zenrelia) and when they should be implemented into treatment plans
- The role of monoclonal antibodies and how Cytopoint can be used as part of patient management
- The ideal cases for allergen specific immunotherapy and testing options
Running time: 1 hr 16 mins (including 16 mins of Q and A)
FREE for VetVine Premium Membership subscribers
Sponsor:
VetVine
Presenter(s):
Jason B. Pieper, DVM, MS, DACVD
Fee (Basic Membership):$50
Pending approval for CE credit by AAVSB RACE. Approved for CE credit by NY State and the NJVMA.
